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House screening for malaria control
After many years in the proverbial wilderness, vector 
control has again risen to prominence in malaria-control 
programmes. WHO now advocates universal coverage 
with longlasting insecticide-treated nets (LLINs), indoor 
residual spraying programmes are being reintroduced 
and expanded, and even larval control, long dismissed as 
inappropriate for sub-Saharan Africa, is being considered 
in selected areas.
In The Lancet today, Matthew Kirby and colleagues1 
show the eﬃ  cacy of another intervention aimed to 
reduce man–vector contact: screening of houses at the 
windows, doors, and eaves, or over the ceilings, lowered 
the numbers of mosquitoes entering houses and 
reduced anaemia in children from those houses. In this 
study, 500 houses were randomly assigned to receive 
full screening, ceiling screens, or no screens. The number 
of mosquitoes captured in traps in houses with full 
screening or screened ceilings was 59% and 47% lower, 
respectively, than the number trapped in houses with no 
screening. Children living in houses with full screening 
or screened ceilings were less likely to be moderately 
anaemic (haemoglobin <80 g/L) than were children 
living in houses with no screening.
Although the beneﬁ ts of house screening might 
seem obvious, its eﬃ  cacy in preventing malaria has not 
previously been assessed in a prospective trial. There 
are many anecdotal reports suggesting that improved 
housing conditions contributed to the elimination of 
malaria in North America and Europe,2,3 but the eﬀ ects of 
these modiﬁ cations were not rigorously measured and 
were probably confounded by other contemporaneous 
vector-control methods.
In today’s evidence-based climate, such anecdotes 
are insuﬃ  cient to convince policy makers. In the USA, 
larval control with Paris Green (a copper acetoarsenite), 
water management, and house spraying with DDT 
(dichlorodiphenyltrichloroethane) are often given most 
credit for the ultimate elimination of malaria. However, 
malaria was in steep decline well before the advent of 
these interventions,4 and some experts have suggested 
that changes in social conditions, including improved 
housing, accounted for much of the decline of malaria 
in Europe and North America.5 This notion does not 
discount DDT and other interventions—they were clearly 
eﬀ ective in uprooting malaria from southeastern USA 
where it was most ﬁ rmly entrenched—but emphasises 
that the contribution of house screening to malaria 
control was probably not trivial.
Despite Kirby and colleagues’ positive results, 
there are several barriers to overcome before house 
screening is given the same priority as interventions 
such as LLINs or indoor residual spraying for malaria-
control programmes. First, evidence from a range 
of ecoepidemiological settings will be needed to 
convince policy makers that this intervention is broadly 
applicable throughout other malarious areas in sub-
Saharan Africa. Second, Kirby rightly points out that 
house screening would be an ideal instrument for 
integrated vector-management. However, today’s study 
was done in a setting with low coverage of insecticide-
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treated nets. Thus the study could not address whether 
the eﬀ ect of house screening would be additive or even 
synergistic with that of LLINs. Resources for malaria 
prevention are limited.
With an already stated global commitment to LLINs, 
robust evidence of equivalence or superiority would 
be needed before resources are diverted from scale-
up of LLINs to house screening. There are also several 
technical questions related to house screening that will 
need to be addressed. For example, how long does the 
screening material last? If a few holes develop, does the 
eﬃ  cacy decline and, if so, should screening material 
be treated with insecticide? In view of the fairly high 
cost of screening, some additional evidence that this 
intervention will last for several years would be needed 
to convince policy makers that house screening is a 
worthwhile investment.
Perhaps the greatest barrier to widescale imple-
mentation of house screening will be the question of 
who pays for it. Kirby and colleagues report that house 
screening in The Gambia costs about US$10 per person if 
netting is donated free of charge, making it much more 
expensive than either LLINs or indoor residual spraying6 
unless the cost is averaged over the expected life of the 
screening material, an approach few donors seem to 
take. The sometimes contentious debates between those 
advocating free nets and those advocating market-
based approaches7,8 are likely to resurface should house 
screening be strongly advocated for malaria prevention. 
Such a debate would be further complicated by the fact 
that those with the largest houses and thus needing the 
most resources are probably those who would be most 
able to aﬀ ord the installation of screening material. 
However, perhaps indoor residual spraying is a more 
appropriate analogy. Itself a rather costly intervention, 
no one thinks about charging homeowners on the basis 
of the square footage of their house.
Despite the challenges to implementing house 
screening, Kirby and colleagues provide evidence that 
this intervention is eﬀ ective in reducing exposure to 
malaria-vector mosquitoes and anaemia in children. 
LLINs and indoor residual spraying have their own 
challenges but are being successfully implemented 
in sub-Saharan Africa. Improved housing might have 
a role in African settings too: several recent studies 
have shown that changes in housing design reduce the 
number of anopheline mosquitoes entering houses,9,10 
and anecdotal evidence suggests that improved 
housing might be associated with a decrease in malaria 
prevalence in Dar es Salaam, Tanzania.11 We hope that 
today’s report will spur further interest in the assessment 
of the potential of house screening to help reduce and 
eventually eliminate malaria.
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